Tuesday, November 8, 2016

BRIEF-Arrowhead Pharmaceuticals provides update on Heparc-2004

* Notified verbally by United States FDA of its decision to

place a clinical hold on heparc-2004

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)